Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8987)
All Articles published online
|
Publishing Process of This Article
|
Jul 21, 2017 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Takata T, Ueda T, Sakasai-Sakai A, Takeuchi M. Generation of glyceraldehyde-derived advanced glycation end-products in pancreatic cancer cells and the potential of tumor promotion. World J Gastroenterol 2017; 23(27): 4910-4919 [PMID: 28785145 DOI: 10.3748/wjg.v23.i27.4910] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v23/i27/4910.htm |
| Number | Citing Articles |
| 1 |
Takanobu Takata, Akiko Sakasai-Sakai, Masayoshi Takeuchi. Intracellular Toxic Advanced Glycation End-Products May Induce Cell Death and Suppress Cardiac Fibroblasts. Metabolites 2022; 12(7): 615 doi: 10.3390/metabo12070615
|
| 2 |
Masayoshi Takeuchi, Hirokazu Suzuki, Kenji Takeda, Akiko Sakai-Sakasai. Toxic advanced glycation end-products (TAGE) are major structures of cytotoxic AGEs derived from glyceraldehyde. Medical Hypotheses 2024; 183: 111248 doi: 10.1016/j.mehy.2023.111248
|
| 3 |
Takanobu Takata, Akiko Sakasai-Sakai, Tadashi Ueda, Masayoshi Takeuchi. Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-39202-5
|
| 4 |
Masayoshi Takeuchi. Toxic AGEs (TAGE) theory: a new concept for preventing the development of diseases related to lifestyle. Diabetology & Metabolic Syndrome 2020; 12(1) doi: 10.1186/s13098-020-00614-3
|
| 5 |
Akiko Sakasai-Sakai, Takanobu Takata, Jun-ichi Takino, Masayoshi Takeuchi. Impact of intracellular glyceraldehyde-derived advanced glycation end-products on human hepatocyte cell death. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14711-3
|
| 6 |
Akiko Sakai-Sakasai, Kenji Takeda, Hirokazu Suzuki, Masayoshi Takeuchi. Structures of Toxic Advanced Glycation End-Products Derived from Glyceraldehyde, A Sugar Metabolite. Biomolecules 2024; 14(2): 202 doi: 10.3390/biom14020202
|
| 7 |
Xiao‐Jun Chen, Wen‐Jun Wu, Qi Zhou, Jin‐Ping Jie, Xiong Chen, Fang Wang, Xiao‐Hua Gong. Retracted: Advanced glycation end‐products induce oxidative stress through the Sirt1/Nrf2 axis by interacting with the receptor of AGEs under diabetic conditions. Journal of Cellular Biochemistry 2019; 120(2): 2159 doi: 10.1002/jcb.27524
|
| 8 |
Takanobu Takata, Akiko Sakasai-Sakai, Masayoshi Takeuchi. Intracellular Toxic Advanced Glycation End-Products in 1.4E7 Cell Line Induce Death with Reduction of Microtubule-Associated Protein 1 Light Chain 3 and p62. Nutrients 2022; 14(2): 332 doi: 10.3390/nu14020332
|
| 9 |
Takanobu Takata, Shinya Inoue, Kenshiro Kunii, Togen Masauji, Katsuhito Miyazawa. Slot Blot- and Electrospray Ionization–Mass Spectrometry/Matrix-Assisted Laser Desorption/Ionization–Mass Spectrometry-Based Novel Analysis Methods for the Identification and Quantification of Advanced Glycation End-Products in the Urine. International Journal of Molecular Sciences 2024; 25(17): 9632 doi: 10.3390/ijms25179632
|
| 10 |
Takanobu Takata, Akiko Sakasai-Sakai, Jun-ichi Takino, Masayoshi Takeuchi. Evidence for Toxic Advanced Glycation End-Products Generated in the Normal Rat Liver. Nutrients 2019; 11(7): 1612 doi: 10.3390/nu11071612
|
| 11 |
Takanobu Takata, Togen Masauji, Yoshiharu Motoo. Analysis of Crude, Diverse, and Multiple Advanced Glycation End-Product Patterns May Be Important and Beneficial. Metabolites 2023; 14(1): 3 doi: 10.3390/metabo14010003
|
| 12 |
Takanobu Takata. Is the Novel Slot Blot a Useful Method for Quantification of Intracellular Advanced Glycation End-Products?. Metabolites 2023; 13(4): 564 doi: 10.3390/metabo13040564
|
| 13 |
Takanobu Takata, Yoshiharu Motoo. Novel In Vitro Assay of the Effects of Kampo Medicines against Intra/Extracellular Advanced Glycation End-Products in Oral, Esophageal, and Gastric Epithelial Cells. Metabolites 2023; 13(7): 878 doi: 10.3390/metabo13070878
|
| 14 |
Akiko Sakasai-Sakai, Kenji Takeda, Masayoshi Takeuchi. Involvement of Intracellular TAGE and the TAGE–RAGE–ROS Axis in the Onset and Progression of NAFLD/NASH. Antioxidants 2023; 12(3): 748 doi: 10.3390/antiox12030748
|
| 15 |
Masayoshi Takeuchi, Akiko Sakasai-Sakai, Takanobu Takata, Jun-ichi Takino, Yoshiki Koriyama, Chigusa Kikuchi, Ayako Furukawa, Kentaro Nagamine, Takamitsu Hori, Tamihide Matsunaga. Intracellular Toxic AGEs (TAGE) Triggers Numerous Types of Cell Damage. Biomolecules 2021; 11(3): 387 doi: 10.3390/biom11030387
|
| 16 |
Takanobu Takata, Togen Masauji, Yoshiharu Motoo. Potential of the Novel Slot Blot Method with a PVDF Membrane for Protein Identification and Quantification in Kampo Medicines. Membranes 2023; 13(12): 896 doi: 10.3390/membranes13120896
|
| 17 |
Guna Ravichandran, Dinesh Kumar Lakshmanan, Karthik Raju, Abbirami Elangovan, Gayathri Nambirajan, Arul Ananth Devanesan, Sivasudha Thilagar. Food advanced glycation end products as potential endocrine disruptors: An emerging threat to contemporary and future generation. Environment International 2019; 123: 486 doi: 10.1016/j.envint.2018.12.032
|
| 18 |
Shinya Inoue, Takanobu Takata, Yusuke Nakazawa, Yuka Nakamura, Xin Guo, Sohsuke Yamada, Yasuhito Ishigaki, Masayoshi Takeuchi, Katsuhito Miyazawa. Potential of an Interorgan Network Mediated by Toxic Advanced Glycation End-Products in a Rat Model. Nutrients 2020; 13(1): 80 doi: 10.3390/nu13010080
|
| 19 |
Masayoshi Takeuchi, Akiko Sakasai-Sakai, Takanobu Takata, Jun-ichi Takino, Yoshiki Koriyama. Effects of Toxic AGEs (TAGE) on Human Health. Cells 2022; 11(14): 2178 doi: 10.3390/cells11142178
|
| 20 |
Lakmini Senavirathna, Sheng Pan, Ru Chen. Protein Advanced Glycation End Products and Their Implications in Pancreatic Cancer. Cancer Prevention Research 2023; 16(11): 601 doi: 10.1158/1940-6207.CAPR-23-0162
|
| 21 |
Shingo Sugiura, Ryosuke Taniguchi, Yoshihiko Nishioka, Ryota Iwase, Reiji Tanaka, Hideo Miyake, Tetsushi Mori, Mitsuyoshi Ueda, Toshiyuki Shibata. Evaluation of Anti-glycation Activities of Phlorotannins in Human and Bovine Serum Albumin-glyceraldehyde Models. Natural Product Communications 2018; 13(8) doi: 10.1177/1934578X1801300820
|
| 22 |
Takanobu Takata, Akiko Sakasai-Sakai, Masayoshi Takeuchi. Impact of intracellular toxic advanced glycation end-products (TAGE) on murine myoblast cell death. Diabetology & Metabolic Syndrome 2020; 12(1) doi: 10.1186/s13098-020-00561-z
|
| 23 |
Lakmini Senavirathna, Cheng Ma, Ru Chen, Sheng Pan. Proteomic Investigation of Glyceraldehyde-Derived Intracellular AGEs and Their Potential Influence on Pancreatic Ductal Cells. Cells 2021; 10(5): 1005 doi: 10.3390/cells10051005
|
| 24 |
Takanobu Takata, Shinya Inoue, Togen Masauji, Katsuhito Miyazawa, Yoshiharu Motoo. Generation and Accumulation of Various Advanced Glycation End-Products in Cardiomyocytes May Induce Cardiovascular Disease. International Journal of Molecular Sciences 2024; 25(13): 7319 doi: 10.3390/ijms25137319
|
| 25 |
Gowri Palanissami, Solomon F. D. Paul. RAGE and Its Ligands: Molecular Interplay Between Glycation, Inflammation, and Hallmarks of Cancer—a Review. Hormones and Cancer 2018; 9(5): 295 doi: 10.1007/s12672-018-0342-9
|